(Q33717173)

28 July 2017

1 reference

title

Decreased antimicrobial resistance after changes in antibiotic use. (English)

1 reference

28 July 2017

Smith DW

1

1 reference

PubMed ID

10456610

28 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

28 July 2017

1 reference

28 July 2017

19

1 reference

28 July 2017

8 Pt 2

1 reference

28 July 2017

129S-132S; discussion 133S-137S

1 reference

Microbial resistance to drug therapy: a review

28 July 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

Antibiotic resistance. Do we need new therapeutic approaches?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

A global gene pool for high-level cephalosporin resistance in commensal Streptococcus species and Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

Enterococcus faecium bacteremia: does vancomycin resistance make a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

Clinical consequences of development of resistance to third generation cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

Epidemiologic perspectives on Enterobacter for the infection control professional

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

Antibiotic usage and methicillin-resistant Staphylococcus aureus: an analysis of causality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

Resistance to antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

Controlling vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.19.12.129S.31702

10.1592/PHCO.19.12.129S.31702

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10456610